Detalles de la búsqueda
1.
[Series of group standards of Technical Specifications for Revision of Safety Information in Marketed Chinese Patent Medicine Instructions].
Zhongguo Zhong Yao Za Zhi
; 47(2): 285-294, 2022 Jan.
Artículo
en Zh
| MEDLINE | ID: mdl-35178969
2.
[Interpretation of Technical Specifications for Revision of Safety Information in Marketed Chinese Patent Medicine Instructions].
Zhongguo Zhong Yao Za Zhi
; 47(2): 295-300, 2022 Jan.
Artículo
en Zh
| MEDLINE | ID: mdl-35178970
3.
[Technical specification for Instructions for Clinical Application of Chinese Patent Medicines in China Association of Chinese Medicine].
Zhongguo Zhong Yao Za Zhi
; 46(17): 4563-4568, 2021 Sep.
Artículo
en Zh
| MEDLINE | ID: mdl-34581062
4.
[Benefit and risk of Tripterygium Glycosides Tablets in treatment of rheumatoid arthritis based on multi-criteria decision-making analysis].
Zhongguo Zhong Yao Za Zhi
; 45(4): 798-808, 2020 Feb.
Artículo
en Zh
| MEDLINE | ID: mdl-32237479
5.
[Pharmacovigilance study on drug-induced cardiac injury during treatment of COVID-19].
Zhongguo Zhong Yao Za Zhi
; 45(10): 2275-2286, 2020 May.
Artículo
en Zh
| MEDLINE | ID: mdl-32495580
6.
Comparative efficacy, safety and cost of oral Chinese patent medicines for rheumatoid arthritis: a Bayesian network meta-analysis.
BMC Complement Med Ther
; 20(1): 210, 2020 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32631398
Resultados
1 -
6
de 6
1
Próxima >
>>